Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Pharaon M, Tichet M, Lebrun-Frénay C, Tartare-Deckert S, Passeron T